Fausto Pinato debate acesso à tirzepatida, regulação e saúde pública | Podcast Acesso & Saúde

Access to tirrizepatide is at the center of one of the most relevant debates in Brazilian public health. In this episode of the ICTQ's Acesso & Saúde podcast, journalist Egle Leonardi interviews lawyer and federal deputy Fausto Pinato (União Brasil-SP), who has been demanding explanations from the National Health Surveillance Agency (Anvisa) and the Ministry of Health regarding the rules governing the commercialization and compounding of the drug in Brazil. During the conversation, Pinato presents his assessment of the impacts of regulation on the population's access to treatment for obesity and type 2 diabetes. The parliamentarian also defends the operation of regulated compounding pharmacies, differentiates legal activity from the clandestine market, and explains the initiatives he has presented in the Chamber of Deputies to question the technical basis of regulatory decisions. The interview also addresses the challenges faced by patients due to the high cost of treatment, the risks of the illegal drug market, and the role of pharmacists in expanding access to healthcare. Presentation: journalist Egle Leonardi Guest: federal deputy Fausto Pinato (União Brasil-SP) Production: ICTQ